Pharmacokinetics and Optimal Dosage of Caspofungin in Critically Ill Patients With Suspected Invasive Candidiasis
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2015
Price : $35 *
At a glance
- Drugs Caspofungin (Primary)
- Indications Candidiasis
- Focus Pharmacokinetics; Therapeutic Use
- 29 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 03 Dec 2013 New trial record